One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...
Cell culture plates in the Roeder lab where scientists recently studied gene expression in breast cancer. (Credit: Lori ...
Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback